Hemolytic anemia in G6PD-deficient children with malaria receiving therapy with a dapsone-containing combination. The 4 panels report the following clinically important parameters: (A) hematocrit; (B) reticulocytes; (C) white blood cell count; and (D) unconjugated bilirubin. In each panel, the shaded area reflects data from the control group (children receiving AL), and the line plots represent mean values ± SE for children receiving a dapsone-containing combination for the 2 male and the 3 female G6PD genotypes. Similar panels for other laboratory parameters are in supplemental Figures 1 and 2.